Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Outterson

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Plos One|October 17, 2018
Introduction and geographic availability of new antibiotics approved between 1999 and 2014Cecilia Kållberg, Christine Årdal, Hege Salvesen Blix, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 8, 2023
A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial EffectivenessIsaac Weldon, Kathy Liddell, Susan Rogers Van Katwyk, et al.
American Journal of Law & Medicine|March 24, 2025
Celebrating 70 Years of Health Law at BUChristopher Robertson, Elizabeth McCuskey, Aziza Ahmed, et al.
Lancet (London, England)|May 26, 2024
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistanceRamanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet. Infectious Diseases|February 16, 2020
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years laterRamanan Laxminarayan, Thomas Van Boeckel, Isabel Frost, et al.
Nature Reviews. Drug Discovery|July 30, 2016
Accelerating global innovation to address antibacterial resistance: introducing CARB-XKevin Outterson, John H Rex, Tim Jinks, et al.
Bulletin of the World Health Organization|December 9, 2020
Social, cultural and economic aspects of antimicrobial resistanceTimo Minssen, Kevin Outterson, Susan Rogers Van Katwyk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Lancet (London, England)|November 20, 2019
A roadmap for sustainably governing the global antimicrobial commonsSusan Rogers Van Katwyk, Manica Balasegaram, Pete Boriello, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Plos One|October 17, 2018
Introduction and geographic availability of new antibiotics approved between 1999 and 2014Cecilia Kållberg, Christine Årdal, Hege Salvesen Blix, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 8, 2023
A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial EffectivenessIsaac Weldon, Kathy Liddell, Susan Rogers Van Katwyk, et al.
American Journal of Law & Medicine|March 24, 2025
Celebrating 70 Years of Health Law at BUChristopher Robertson, Elizabeth McCuskey, Aziza Ahmed, et al.
Lancet (London, England)|May 26, 2024
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistanceRamanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet. Infectious Diseases|February 16, 2020
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years laterRamanan Laxminarayan, Thomas Van Boeckel, Isabel Frost, et al.
Nature Reviews. Drug Discovery|July 30, 2016
Accelerating global innovation to address antibacterial resistance: introducing CARB-XKevin Outterson, John H Rex, Tim Jinks, et al.
Bulletin of the World Health Organization|December 9, 2020
Social, cultural and economic aspects of antimicrobial resistanceTimo Minssen, Kevin Outterson, Susan Rogers Van Katwyk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Lancet (London, England)|November 20, 2019
A roadmap for sustainably governing the global antimicrobial commonsSusan Rogers Van Katwyk, Manica Balasegaram, Pete Boriello, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
Pageof 8